Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 2402

    1.

    Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005.

    Datta SD, Koutsky LA, Ratelle S, Unger ER, Shlay J, McClain T, Weaver B, Kerndt P, Zenilman J, Hagensee M, Suhr CJ, Weinstock H.

    Ann Intern Med. 2008 Apr 1;148(7):493-500.PMID: 18378945 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

    Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M.

    J Natl Cancer Inst. 2003 Jan 1;95(1):46-52.PMID: 12509400 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.

    Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA.

    JAMA. 2002 Oct 9;288(14):1749-57.PMID: 12365959 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Summaries for patients. Results of Pap smears and human papillomavirus tests during cervical cancer screening.

    [No authors listed]

    Ann Intern Med. 2008 Apr 1;148(7):I32. No abstract available. PMID: 18378942 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.

    Wright TC Jr, Denny L, Kuhn L, Pollack A, Lorincz A.

    JAMA. 2000 Jan 5;283(1):81-6.PMID: 10632284 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.

    Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dillner J.

    J Natl Cancer Inst. 2004 Feb 18;96(4):280-93.PMID: 14970277 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    [A comparison of human papillomavirus detection and ThinPrep cytology test for women in Guangdong province]

    Xue YH, Chen ZX, Zheng BW, Zhang JM, Zhu QY.

    Zhonghua Zhong Liu Za Zhi. 2005 May;27(5):283-5. Chinese. PMID: 15996320 [PubMed - indexed for MEDLINE]Related articles

    8.

    Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear.

    Arora R, Kumar A, Prusty BK, Kailash U, Batra S, Das BC.

    Eur J Obstet Gynecol Reprod Biol. 2005 Jul 1;121(1):104-9.PMID: 15950365 [PubMed - indexed for MEDLINE]Related articles

    9.

    Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, West-African women over 35 years of age.

    Xi LF, Touré P, Critchlow CW, Hawes SE, Dembele B, Sow PS, Kiviat NB.

    Int J Cancer. 2003 Mar 1;103(6):803-9.PMID: 12516102 [PubMed - indexed for MEDLINE]Related articles

    10.

    New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors.

    Syrjänen K.

    Eur J Gynaecol Oncol. 2008;29(3):205-21.PMID: 18592782 [PubMed - indexed for MEDLINE]Related articles

    11.

    Prevalence of the human papillomavirus in an inner-city indigent population with previously normal Pap tests.

    Werden J, Schnatz PF, Mandavilli S, Allen G, Murphy JL, Greene JF, Egan JF, Sorosky JI.

    J Low Genit Tract Dis. 2008 Oct;12(4):287-92.PMID: 18820543 [PubMed - indexed for MEDLINE]Related articles

    12.

    Oncogenic human papillomavirus infection and cervical lesions in aboriginal women of Nunavut, Canada.

    Healey SM, Aronson KJ, Mao Y, Schlecht NF, Mery LS, Ferenczy A, Franco EL.

    Sex Transm Dis. 2001 Dec;28(12):694-700.PMID: 11725224 [PubMed - indexed for MEDLINE]Related articles

    13.

    Age-related performance of human papillomavirus testing used as an adjunct to cytology for cervical carcinoma screening in a population with a low incidence of cervical carcinoma.

    Petignat P, Faltin D, Goffin F, Billieux MH, Stucki D, Sporri S, Vassilakos P.

    Cancer. 2005 Jun 25;105(3):126-32.PMID: 15822123 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

    Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M.

    J Natl Cancer Inst. 2005 Jul 20;97(14):1072-9.PMID: 16030305 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico.

    Salmerón J, Lazcano-Ponce E, Lorincz A, Hernández M, Hernández P, Leyva A, Uribe M, Manzanares H, Antunez A, Carmona E, Ronnett BM, Sherman ME, Bishai D, Ferris D, Flores Y, Yunes E, Shah KV.

    Cancer Causes Control. 2003 Aug;14(6):505-12.PMID: 12948281 [PubMed - indexed for MEDLINE]Related articles

    16.

    Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy.

    Schneider A, Hoyer H, Lotz B, Leistritza S, Kühne-Heid R, Nindl I, Müller B, Haerting J, Dürst M.

    Int J Cancer. 2000 Nov 20;89(6):529-34.PMID: 11102899 [PubMed - indexed for MEDLINE]Related articles

    17.

    Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.

    Verguts J, Bronselaer B, Donders G, Arbyn M, Van Eldere J, Drijkoningen M, Poppe W.

    BJOG. 2006 Nov;113(11):1303-7. Epub 2006 Sep 15.PMID: 16978225 [PubMed - indexed for MEDLINE]Related articles

    18.

    Pap cytopathology and the presence of high-risk human papillomavirus in SurePath liquid preservative and Digene cervical sampler specimens.

    Kapala J, Jang D, Patel J, Biers K, Smieja M, Chernesky M.

    J Virol Methods. 2007 Jun;142(1-2):223-5. Epub 2007 Feb 23.PMID: 17320978 [PubMed - indexed for MEDLINE]Related articles

    19.

    PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears.

    Rozendaal L, Walboomers JM, van der Linden JC, Voorhorst FJ, Kenemans P, Helmerhorst TJ, van Ballegooijen M, Meijer CJ.

    Int J Cancer. 1996 Dec 11;68(6):766-9.PMID: 8980181 [PubMed - indexed for MEDLINE]Related articles

    20.

    Evaluation of primary cervical cancer screening with an oncogenic human papillomavirus DNA test and cervical cytologic findings among women who attended family planning clinics in the United States.

    Baseman JG, Kulasingam SL, Harris TG, Hughes JP, Kiviat NB, Mao C, Koutsky LA.

    Am J Obstet Gynecol. 2008 Jul;199(1):26.e1-8. Epub 2008 Mar 7.PMID: 18313636 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data